ArticleParkinson's disease2026
Acupuncture-Related Therapies as a Potential Adjuvant Option for Parkinson's Disease: Effects on Symptom Management, Medication Use, and Mortality.
Article in Parkinson's disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: There is increasing demand for an effective adjuvant therapies for Parkinson's disease (PD) patients to minimize side effects and improve quality of life, due to unmet needs not fully addressed by conventional treatments. Objectives: To examine the long-term effects of adjuvant acupuncture-related therapies on medication use and mortality in patients with PD using the National Health Insurance Service (NHIS) database in Korea. Methods: NHIS records from 2010 to 2011 were searched to extract the study population. The medical records of patients with PD were followed from the initial diagnosis to August 2018. Propensity score matching was performed using covariates, including age group, sex, and duration of levodopa therapy. Odds ratios (ORs) of levodopa therapy and nonmotor symptom medication use were examined. Cox proportional hazards modeling and Kaplan-Meier analysis were performed to determine differences between acupuncture-related therapy users (ACU group) and nonusers (non-ACU group). Results: The ACU group ( Conclusion: Acupuncture-related therapies-defined here as one or more treatments delivered at Korean medicine clinics, including acupuncture, electroacupuncture, moxibustion, cupping, and herbal formulations-were more frequently received by patients with nonmotor symptoms. The use of levodopa therapy and all-cause mortality was lower in the ACU group than in the non-ACU group. Given the observational design, heterogeneity of the exposure, and potential residual confounding, these associations should not be interpreted as causal evidence of therapeutic benefit. Prospective, randomized, sham-controlled trials are required to determine whether acupuncture-related therapies confer specific clinical benefit in patients with PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.